bupranolol

This page covers all bupranolol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-2 adrenergic receptor.

Targets

Beta-2 adrenergic receptor

Phase 2 pipeline (1)

• Bupranol · Cardiovascular
  Bupranol works by blocking the beta-2 adrenergic receptor, which helps to reduce the pressure in the eye and lower blood pressure.

Patent intelligence

• bupranolol patent landscape — aggregated cliff calendar, attackable patents, originator estates